Asia Pacific Western Blotting Market Size & Outlook
Related Markets
Asia Pacific western blotting market highlights
- The Asia Pacific western blotting market generated a revenue of USD 389.3 million in 2024.
- The market is expected to grow at a CAGR of 6.8% from 2025 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2024.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 389.3 million |
| Market revenue in 2030 | USD 575.0 million |
| Growth rate | 6.8% (CAGR from 2025 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables |
| Key market players worldwide | Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., LI-COR, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd., Bio-Techne Corp, GE Healthcare, Qiagen NV, Cell Signaling Technology |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.8% of the global western blotting market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 575.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Western Blotting Market Scope
Western Blotting Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| LI-COR, Inc. | View profile | - | - | - |
| GE Healthcare | View profile | - | - | - |
| Thermo Fisher Scientific Inc. | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Bio-Rad Laboratories, Inc. | View profile | - | - | - |
| Cell Signaling Technology | View profile | 501-1000 | Danvers, Massachusetts, United States, North America | https://www.cellsignal.com |
| Bio-Techne Corp | View profile | 3050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | https://www.bio-techne.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Asia Pacific western blotting market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to western blotting market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 73.62% in 2024. Horizon Databook has segmented the Asia Pacific western blotting market based on instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Asia Pacific western blotting market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific western blotting market databook
-
Our clientele includes a mix of western blotting market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific western blotting market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific western blotting market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific western blotting market size, by country, 2018-2030 (US$M)
Asia Pacific Western Blotting Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
